Karuna Therapeutics

schizophrenia bipolar disorder neuropsychiatry

Pharma

BMS partner Zai Lab eyes China filing for KarXT after trial win

Following a China-based schizophrenia trial win, Bristol Myers partner Zai Lab is moving fast to expand the global reach of novel antipsychotic KarXT.

Fraiser Kansteiner Oct 29, 2024 1:59pm

BMS' schizophrenia gem Cobenfy was salvaged from the scrapheap

Oct 7, 2024 3:00am

schizophrenia mental health brain neurodegenerative

BMS wins FDA approval for new schizophrenia med Cobenfy

Sep 26, 2024 7:38pm

BMS' dealmaking appetite remains intact, CEO says

Jun 12, 2024 10:55am

Alkermes reports strong trajectory for Lybalvi, shares up 10%

Feb 15, 2024 1:10pm

‘The Top Line’: The most anticipated drug launches of 2024

Feb 9, 2024 6:00am